Bryant D. Lim

Insider Reports History

Entity
Individual
Location
C/O Idera Pharmaceuticals, Inc., 505 Eagleview Blvd., Suite 212, Exton, PA
Signature
/s/ Bryant D. Lim
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Bryant D. Lim:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Prelude Therapeutics Inc CLO, Interim CFO, Corp Sec. Common Stock 27.4K $24.8K $0.91 Dec 19, 2024 Direct
Aceragen, Inc. SVP AND GENERAL COUNSEL Stock Options (Right to Buy) 25.4K Jan 20, 2023 Direct
Prelude Therapeutics Inc CLO, Interim CFO, Corp Sec. Employee Stock Option (Right to Buy) 25K May 14, 2024 Direct

Insider Reports Filed by Bryant D. Lim

Symbol Company Period Transactions Value $ Form Type Date Filed Role
PRLD Prelude Therapeutics Inc Dec 19, 2024 1 $22.6K 4 Dec 20, 2024 CLO, Interim CFO, Corp Sec.
PRLD Prelude Therapeutics Inc May 14, 2024 1 $0 4 May 16, 2024 CLO, Interim CFO, Corp Sec.
PRLD Prelude Therapeutics Inc Mar 1, 2024 1 $0 4 Mar 4, 2024 Chief Legal Officer, Corp Sec.
PRLD Prelude Therapeutics Inc May 24, 2023 1 $12.9K 4 May 25, 2023 Chief Legal Officer, Corp Sec.
PRLD Prelude Therapeutics Inc Mar 1, 2023 1 $0 4 Mar 2, 2023 Chief Legal Officer, Corp Sec.
PRLD Prelude Therapeutics Inc Feb 20, 2023 0 $0 3 Feb 22, 2023 Chief Legal Counsel, Corp Sec.
ACGN Aceragen, Inc. Jan 20, 2023 1 $0 4 Feb 2, 2023 SVP AND GENERAL COUNSEL
IDRA IDERA PHARMACEUTICALS, INC. Jan 6, 2023 2 -$85.2K 4 Jan 10, 2023 SVP AND GENERAL COUNSEL
IDRA IDERA PHARMACEUTICALS, INC. Jul 6, 2022 1 $0 4 Jul 7, 2022 SVP AND GENERAL COUNSEL
IDRA IDERA PHARMACEUTICALS, INC. Apr 1, 2022 1 $0 4 Apr 4, 2022 SVP AND GENERAL COUNSEL
IDRA IDERA PHARMACEUTICALS, INC. Jan 24, 2022 1 $0 4 Jan 26, 2022 SVP AND GENERAL COUNSEL
IDRA IDERA PHARMACEUTICALS, INC. Jul 8, 2021 1 $0 4 Jul 12, 2021 SVP AND GENERAL COUNSEL